ArthritisNCT00377884
Serologic Characterization of Bone-healing
An observational study of Arthritis, run by Northern Orthopaedic Division, Denmark at 2 sites in Denmark.
Trial summary
Investigation of serologic bone markers in patients undergoing hip arthroplasty Read more about this study
- Who is it for?
- Ages 40 to 80 years
- Conditions the study is for
- Arthritis
- How many people
- 0 participants
- Where
- 2 sitesDenmark
- Study dates
- Jan 2004to Jun 2009
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 40 to 80 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: patients planned for cementless THR for OA in the hip
Who may be able to join
- Ages 40-80 years
Who cannot join
None listed.
Trial locations and contacts
2 sites in 1 country.
Denmark2 sites
Northern Orthopaedic Division
Aalborg, Northern Jutland
Aalborg University Hospital
Aalborg, 9000
About this study
Official title: Serologic Based Molecular Characterization of Bone-healing After Cementless Total Hip Arthroplasty
Investigation of serologic bone markers in patients undergoing hip arthroplasty
Read the detailed description
Investigation of serologic bone markers in patients undergoing hip arthroplasty. Measured by frequent blood- and urine samples pre-operative and during the first post-operative year.
- Conditions
- Arthritis
- Keywords
- THA
- Medical subject headings
- Arthritis
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted19 Sep 2006 (estimated)
- Study startJan 2004
- Primary completionJun 2009
- Study completionJun 2009 (estimated)
Why it stopped: Lack of patients, lack of funding for analysis
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for ArthritisStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 0 participants (actual)
Sponsor and investigators
- Lead sponsor
- Northern Orthopaedic Division, Denmark
- Sponsor type
- University, hospital or other
- Collaborators
- CCBR Clinical Research Center, Aalborg, Denmark
- Investigators
- Mogens B Laursen, MD, Phd, Principal investigator, Northern Orthopaedic Division
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT00377884
- Sponsor's protocol ID
- ON-04-018-MBL
- Status last verified
- Apr 2014
- First submitted
- 18 Sep 2006
- Last updated
- 3 Apr 2014
- Results posted
- No
Study at a glance
From the registry record, last updated by the sponsor on 3 Apr 2014. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Serologic Based Molecular Characterization of Bone-healing After Cementless Total Hip Arthroplasty
- ClinicalTrials.gov ID
- NCT00377884
- Acronym / sponsor ID
- ON-04-018-MBL
- Conditions
- Arthritis
- Keywords
- THA
- Study type
- Observational
- Recruitment status
- WithdrawnReason stopped: Lack of patients, lack of funding for analysis
- Enrolment
- 0 participants (actual)
- Lead sponsor
- Northern Orthopaedic Division, DenmarkUniversity, hospital or other
- Collaborators
- CCBR Clinical Research Center, Aalborg, Denmark
- Study start
- Jan 2004
- Primary completion
- Jun 2009 (actual)
- Study completion
- Jun 2009 (estimated)
- First posted
- 19 Sep 2006 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Investigation of serologic bone markers in patients undergoing hip arthroplasty
Detailed description
Investigation of serologic bone markers in patients undergoing hip arthroplasty. Measured by frequent blood- and urine samples pre-operative and during the first post-operative year.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
Who may qualify
- Ages
- 40 to 80 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- patients planned for cementless THR for OA in the hip
Key inclusion criteria (1 listed)
- Ages 40-80 years
Key exclusion criteria (0 listed)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Not reported in the source record.
Results and safety
The study was withdrawn before enrolling participants, so there are no results.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 3 Apr 2014.
Related trials for Arthritis
Active, not recruitingObservational study
Frequency and Complications of Major Orthopedic Procedures in Medicare Beneficiaries
Rheumatoid Arthritis, Ankylosing Spondylitis
RecruitingPhase 2
COVID-19 Booster and IIV Schedule in Immunocompromised Hosts
COVID 19, Influenza
Not yet recruitingObservational study
Pain Phenotyping of Rheumatic Diseases - An Observational Study
Rheumatic Diseases, Lupus Erythematosus, Systemic
Not yet recruitingPhase 2
A Clinical Trial of MK-8690 in Participants With Rheumatoid Arthritis (MK-8690-004)
Rheumatoid Arthritis
RecruitingObservational study
Natural History and Development of Spondyloarthritis
Arthritis, Spondylitis, Ankylosing
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Mogens B Laursen, MD, Phd principal investigator
Northern Orthopaedic Division
2 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Arthritis, run by Northern Orthopaedic Division, Denmark at 2 sites in Denmark.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: withdrawn, as of the sponsor's last update on 3 Apr 2014. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 2 sites in Denmark. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study was withdrawn before enrolling participants, so there are no results.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Apr 2014; AzTrials last refreshed its copy on 26 Oct 2026.